269 related articles for article (PubMed ID: 30048054)
1. The importance of serum interleukin-20 levels in patients with Behçet's disease.
Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
[TBL] [Abstract][Full Text] [Related]
2. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
[TBL] [Abstract][Full Text] [Related]
3. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
Balkarli A; Kucuk A; Babur H; Erbasan F
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
[TBL] [Abstract][Full Text] [Related]
6. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
9. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
10. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between serum IL-9 levels and Behçet's disease.
Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
[TBL] [Abstract][Full Text] [Related]
13. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.
Adam B; Calikoglu E
J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143
[TBL] [Abstract][Full Text] [Related]
16. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features.
Zarrabi M; Gholijani N; Shenavandeh S; Aflaki E; Amirghofran Z
Eur Cytokine Netw; 2019 Sep; 30(3):82-87. PubMed ID: 31957702
[TBL] [Abstract][Full Text] [Related]
17. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
[TBL] [Abstract][Full Text] [Related]
19. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
20. Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease.
Cingu AK; Turkcu FM; Aktas S; Sahin A; Ayyildiz O
Int Ophthalmol; 2020 Dec; 40(12):3441-3451. PubMed ID: 32729061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]